Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q1 EPS by 2c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $79.27 --0%
Revenue Growth %: +89.5%
Financial Fact:
Change in value of derivatives: -113.36K
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: +89.5%
Financial Fact:
Change in value of derivatives: -113.36K
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q1 EPS of ($0.03), $0.02 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $29.5 million versus the consensus estimate of $29.5 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk stock target lifted by Citi on continued demand strength
- Accor downgraded to “hold” at Jefferies as Middle East RevPAR plunges
- Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
